Study shows heart risks of Trump antimalarial drug

A study from the medical journal the Lancet found the antimalarial
drug that US President Donald Trump has taken is linked to increased
risk of death in COVID-19 patients.

Nearly 100,000 patients who were treated with hydroxychloroquine
suffered a greater chance of heart attacks.

Nick Harper reports from Washington.

IN: "96,000 patients..."
OUT: SOC
DUR: 39 seconds

http://fsnradionews.com/feeds/0522drug-nh.mp3